0001209191-22-007887.txt : 20220208 0001209191-22-007887.hdr.sgml : 20220208 20220208202356 ACCESSION NUMBER: 0001209191-22-007887 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220207 FILED AS OF DATE: 20220208 DATE AS OF CHANGE: 20220208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARCIA PETER S CENTRAL INDEX KEY: 0001188956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 22603475 MAIL ADDRESS: STREET 1: ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-07 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001188956 GARCIA PETER S C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 0 1 0 0 Chief Financial Officer Common Stock 2022-02-07 4 M 0 6637 4.08 A 16120 D Common Stock 2022-02-07 4 M 0 8363 4.81 A 24483 D Employee Stock Option (right to buy) 4.08 2022-02-07 4 M 0 6637 0.00 D 2030-03-09 Common Stock 6637 89022 D Employee Stock Option (right to buy) 4.08 2030-03-09 Common Stock 60468 60468 D Employee Stock Option (right to buy) 4.81 2022-02-07 4 M 0 8363 0.00 D 2030-04-27 Common Stock 8363 20813 D Includes 152 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter. The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter. One-fourth of the shares subject to the option vest on April 27, 2021 and 1/36th of the remaining shares vest monthly thereafter. /s/ Peter Garcia 2022-02-08